COVID-19 Information Center

Transmission electron microscopic image of an isolate from a case of coronavirus disease (COVID-19)
  • Coronavirus disease

COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) with safety of associates and patients globally as our primary concern. We are also contributing to research efforts, supporting communities and ensuring stable supply and price of essential medicines. This information center provides a central hub for updates, guidance and other resources.

Novartis response to COVID-19

In the face of a global crisis, Novartis has quickly mobilized R&D capabilities, medicines, clinical trials expertise and philanthropic aid to address the coronavirus disease pandemic.

Read More

Latest news

Molecular Partners and Novartis report positive initial results from Phase 1 study of COVID-19 antiviral therapy

Read More

Novartis signs initial agreement to provide manufacturing capacity for CureVac COVID-19 vaccine candidate

The agreement will see Novartis utilizing its new high-tech production facilities in Kundl, Austria.

Read More

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland.

Read More

Update on Novartis RUXCOVID trial

The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.

Read More

Novartis COVID-19 Response Fund

The fund, launched in March 2020, has supported public health initiatives to help communities manage challenges posed by COVID-19.

Watch the video

Perspectives

COVID one year on: Learning the lessons for sustainable patient access

CEO of Sandoz, Richard Saynor, reflects on the past year and on-going efforts to maintain overall manufacturing and supply security for essential medicines.

Learn More

Moving towards the next normal

How changes driven by COVID-19 may shape pharma manufacturing in the long term.

Read More

Supply chain organization during the COVID-19 pandemic

Balancing priorities of combating the crisis and ongoing trials.

Read More

Coronavirus and the Art of Unbossed Leadership

Novartis CEO Vas Narasimhan talks with Fortune editor-in-chief Clifton Leaf about health care's present and future. Read the entire article.

Latest stories

Novartis helps COVID-19 vaccine supply

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Read More

Containing COVID-19 to serve patient needs

The coronavirus crisis has not only challenged the medical community to seek new treatments and vaccines. Keeping up with the production of existing drugs is equally challenging. Novartis has taken a series of measures to maintain production levels and serve millions of patients.

Read More

Novartis COVID-19 Stories

Read how Novartis is approaching the pandemic through the eyes of its associates.

Learn More

Guidance
  • Woman looking at an Ipad in a waiting room

    Patients and Caregivers

    Novartis is working to ensure supply of our medicines, enhance virtual services, protect the integrity of clinical trials and support patient organizations during the coronavirus disease (COVID-19) pandemic.

  • Doctors washing their hands

    Healthcare Professionals

    Novartis is working closely with healthcare professionals during the coronavirus disease pandemic. We are embracing new ways of working and have rapidly scaled up multichannel engagement.

  • Businessman with digital tablet

    Investors and Shareholders

    Novartis is regularly updating our Investor and Shareholder communities on the impact of coronavirus disease (COVID-19) and our response.

  • Business people working on a computer

    Job candidates

    Novartis is supporting candidates during the coronavirus disease (COVID-19) outbreak. During this time interviews will continue as planned and, where appropriate, will be switched to virtual interviews using readily available technology.

  • Man preparing a package

    Suppliers

    Novartis is providing suppliers with recommended good practices guidance during the coronavirus disease (COVID-19) pandemic based on the most up-to-date World Health Organization (WHO) technical information.

  • Grey and white world map

    COVID-19 country resources

    Novartis provides country-specific information about coronavirus disease (COVID-19) in local languages.

Novartis COVID-19 Response Fund

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

Learn More

Research and collaborations
Resources